SQZ Biotechnologies Company (SQZ) Tops Q3 EPS by 5c

SQZ Biotechnologies Company (NYSE: SQZ) reported Q3 EPS of ($0.77), $0.05 better than the analyst estimate of ($0.82). Revenue for the quarter came in at $3.5 million versus the consensus estimate of $4.47 million.

For earnings history and earnings-related data on SQZ Biotechnologies Company (SQZ) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15